2025 annual financial data
aTyr Pharma 2025 Operating margin
Direct answer
Operating margin was -40,856.32%.
Operating income was -77,627,000 USD and net income was -74,118,000 USD.
Operating cash flow was -61,986,000 USD.
Get free aTyr Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 190,000 USD
- Operating income
- -77,627,000 USD
- Net income
- -74,118,000 USD
- Operating cash flow
- -61,986,000 USD